Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05768464
What this trial is testing

Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors

Who this might be right for
Non-clear Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Ended earlyNCT03387514
What this trial is testing

Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies

Who this might be right for
Renal Cell Carcinoma
University of Wisconsin, Madison 5
Testing effectiveness (Phase 2)Study completedNCT00244764
What this trial is testing

GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 225
Large-scale testing (Phase 3)Looking for participantsNCT07011719
What this trial is testing

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc. 720
Testing effectiveness (Phase 2)UnknownNCT03280667
What this trial is testing

Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma, Clear CellMetastatic Kidney Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 59
Testing effectiveness (Phase 2)Study completedNCT01715935
What this trial is testing

Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus

Who this might be right for
Clear-cell Renal CarcinomaClear-cell Metastatic Renal Cell Carcinoma
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 25
Early research (Phase 1)Study completedNCT02575222
What this trial is testing

Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Testing effectiveness (Phase 2)Looking for participantsNCT05287945
What this trial is testing

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Oncorena AB 75
Large-scale testing (Phase 3)Ended earlyNCT02535351
What this trial is testing

Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 13
Testing effectiveness (Phase 2)Study completedNCT00408902
What this trial is testing

Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00550277
What this trial is testing

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma
SCRI Development Innovations, LLC 20
Early research (Phase 1)Ended earlyNCT04438083
What this trial is testing

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Who this might be right for
Renal Cell Carcinoma
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT01217931
What this trial is testing

Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT00324870
What this trial is testing

Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Ended earlyNCT00561912
What this trial is testing

Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Ended earlyNCT00491075
What this trial is testing

Pemetrexed Plus Gemcitabine in Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT03108066
What this trial is testing

MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)

Who this might be right for
VHL Gene MutationVHLVHL Syndrome+8 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 4
Testing effectiveness (Phase 2)Ended earlyNCT00131651
What this trial is testing

ATN-161 in Advanced Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
Attenuon 36
Early research (Phase 1)Study completedNCT01672775
What this trial is testing

Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

Who this might be right for
Carcinoma, Renal CellRenal Cell Carcinoma of Papillary HistologyRenal Cell Carcinoma With Clear Cell Histology+1 more
Agensys, Inc. 34